Is Methotrexate Safe with Folic Acid?
Yes, folic acid supplements are safe—and standard—with methotrexate. Doctors routinely prescribe low-dose folic acid (1-5 mg daily or weekly) to reduce methotrexate's side effects without blocking its effectiveness in treating rheumatoid arthritis, psoriasis, or cancer.[1][2]
Why Take Folic Acid with Methotrexate?
Methotrexate inhibits dihydrofolate reductase, depleting folate and causing toxicity like nausea, mouth sores, fatigue, and elevated liver enzymes. Folic acid replenishes folate stores, cutting gastrointestinal issues by up to 79%, mouth ulcers by 72%, and liver problems by 28%.[3][4] Studies show it preserves methotrexate's disease control in rheumatoid arthritis patients.[5]
Recommended Dosing and Timing
- Dose: 1 mg daily or 5 mg weekly (often 5 mg the day after methotrexate).
- Timing: Avoid same-day dosing with methotrexate to prevent interference; take 24-48 hours later.
- Form: Folic acid works; folinic acid (leucovorin) is stronger for high-dose chemo but costlier.[2][6]
Guidelines from the American College of Rheumatology endorse this for rheumatoid arthritis.[7]
What If You Skip Folic Acid?
Untreated folate depletion raises risks of severe nausea (79% higher), infections, hair loss, and liver fibrosis. Long-term, it increases non-liver toxicities by 56%.[3][8] Patients often quit methotrexate without it due to side effects.
Risks or Interactions to Watch
No major safety issues; rare over-supplementation concerns don't apply at these doses. Monitor bloodwork for liver function and folate levels. Avoid if allergic to folate. High-dose methotrexate (cancer) needs medical oversight for leucovorin rescue.[2][9]
Patient Experiences and Studies
In trials of 1,000+ rheumatoid arthritis patients, folic acid users reported 20-30% fewer withdrawals from therapy.[5] Real-world data confirms tolerability; forums note fewer "methotrexate fog" symptoms.[10]
[1]: American College of Rheumatology Guidelines
[2]: UpToDate: Methotrexate and Folic Acid
[3]: van Ede AE et al., Lancet (2001)
[4]: Whittle SL, Preiss AK, et al., Cochrane Review (2013)
[5]: Shea B et al., Cochrane Database Syst Rev (2013)
[6]: Howard SC et al., J Clin Oncol (2005)
[7]: Singh JA et al., Arthritis Care Res (2016)
[8]: Dhir V et al., Clin Rheumatol (2014)
[9]: Kremer JM et al., Arthritis Rheum (1994)
[10]: Patient surveys via Arthritis Foundation reports